Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer. | Cell Mol Life Sci | 2023 | 37815603 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals partial epithelial-mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy. | Physiol Rep | 2023 | 37813528 | PubTator, text mining | PubMed |
M2-like tumor-associated macrophages promote epithelial-mesenchymal transition through the transforming growth factor β/Smad/zinc finger e-box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma. | Cancer Sci | 2023 | 37806311 | PubTator, text mining | PubMed |
| Epigenomic signature of major congenital heart defects in newborns with Down syndrome. | Hum Genomics | 2023 | 37803336 | PubTator, text mining | PubMed |
| The role of angiogenic growth factors in the immune microenvironment of glioma. | Front Oncol | 2023 | 37790751 | PubTator, text mining | PubMed |
| Metabolic response to CNS infection with flaviviruses. | J Neuroinflammation | 2023 | 37775774 | PubTator, text mining | PubMed |
| Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial. | Breast Cancer Res | 2023 | 37773134 | PubTator, text mining | PubMed |
| Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer. | J Funct Biomater | 2023 | 37754880 | PubTator, text mining | PubMed |
| The prognostic value of tumor-associated macrophages in glioma patients. | Medicine (Baltimore) | 2023 | 37747032 | PubTator, text mining | PubMed |
| Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article. | Blood Lymphat Cancer | 2023 | 37731771 | PubTator, text mining | PubMed |
| The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. | Front Immunol | 2023 | 37731483 | PubTator, text mining | PubMed |
| Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction. | J Transl Med | 2023 | 37726803 | PubTator, text mining | PubMed |
| ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma. | EXCLI J | 2023 | 37720239 | PubTator, text mining | PubMed |
| Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer. | J Immunol Res | 2023 | 37719086 | PubTator, text mining | PubMed |
| Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis. | Phytomedicine | 2023 | 37716031 | PubTator, text mining | PubMed |
| Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37701562 | PubTator, text mining | PubMed |
| Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. | Nat Commun | 2023 | 37684223 | PubTator, text mining | PubMed |
| Prognostic factors for persistent obstructive symptoms in patients with Hirschsprung disease following pull-through. | PLoS One | 2023 | 37682877 | PubTator, text mining | PubMed |
| The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications. | Mol Cancer | 2023 | 37679744 | PubTator, text mining | PubMed |
| RAS signaling and immune cells: a sinister crosstalk in the tumor microenvironment. | J Transl Med | 2023 | 37670322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=15